Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non-interventional study in Kenya.
White T, Selvarajah V, Wolfhagen-Sand F, Svangård N, Mohankumar G, Fenici P, Rough K, Onyango N, Lyons K, Mack C, Nduba V, Noorali Saleh M, Abayo I, Siddiqui A, Majdanska-Strzalka M, Kaszubska K, Hegelund-Myrback T, Esterline R, Manzur A, Parker VER. White T, et al. Among authors: fenici p. Diabetes Obes Metab. 2024 Apr 15. doi: 10.1111/dom.15587. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38618987
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management.
Vora J, Cherney D, Kosiborod MN, Spaak J, Kanumilli N, Khunti K, Lam CSP, Bachmann M, Fenici P; CaReMe Global Alliance. Vora J, et al. Among authors: fenici p. Diabetes Obes Metab. 2024 May;26(5):1567-1581. doi: 10.1111/dom.15485. Epub 2024 Feb 8. Diabetes Obes Metab. 2024. PMID: 38328853 Review.
DAPA-HF applicability: the point of view of a cardiology setting.
Iacoviello M, Marini M, Gori M, Orso F, Gonzini L, Gorini M, Fenici P, Maggioni AP. Iacoviello M, et al. Among authors: fenici p. Acta Cardiol. 2023 Sep;78(7):840-845. doi: 10.1080/00015385.2023.2243130. Epub 2023 Aug 22. Acta Cardiol. 2023. PMID: 37605991
Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetes.
Aarskog P, Cid-Ruzafa J, Chen H, Fenici P, Gutierrez LR, Hammar N, Medina J, Pascual E, Saraiva GL, Surmont F, Sweet S, Ji L, Khunti K, Cooper A. Aarskog P, et al. Among authors: fenici p. Prim Care Diabetes. 2023 Oct;17(5):411-419. doi: 10.1016/j.pcd.2023.07.002. Epub 2023 Aug 5. Prim Care Diabetes. 2023. PMID: 37544790 Free article. Review.
Highlights from the 1st European cancer dependency map symposium and workshop.
Trastulla L, Savino A, Beltrao P, Ciriano IC, Fenici P, Garnett MJ, Guerini I, Bigas NL, Mattaj I, Petsalaki E, Riva L, Tape CJ, Leeuwen JV, Sharma S, Vazquez F, Iorio F. Trastulla L, et al. Among authors: fenici p. FEBS Lett. 2023 Aug;597(15):1921-1927. doi: 10.1002/1873-3468.14699. Epub 2023 Jul 24. FEBS Lett. 2023. PMID: 37487655
Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study.
Goh SY, Kosiborod MN, Lam CSP, Cavender MA, Kohsaka S, Norhammar A, Birkeland KI, Holl RW, Mauricio D, Tangri N, Shaw JE, Thuresson M, Fenici P, Kim DJ; CVD-REAL Investigators and Study Group. Goh SY, et al. Among authors: fenici p. Diabetes Obes Metab. 2023 Aug;25(8):2402-2409. doi: 10.1111/dom.15092. Epub 2023 May 8. Diabetes Obes Metab. 2023. PMID: 37055714 No abstract available.
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
Bongaerts B, Kuss O, Bonnet F, Chen H, Cooper A, Fenici P, Gomes MB, Hammar N, Ji L, Khunti K, Medina J, Nicolucci A, Shestakova MV, Watada H, Rathmann W. Bongaerts B, et al. Among authors: fenici p. Diabetes Obes Metab. 2023 Jul;25(7):1890-1899. doi: 10.1111/dom.15050. Epub 2023 Apr 5. Diabetes Obes Metab. 2023. PMID: 36906837
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Charbonnel BH, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Saraiva GL, Medina J, Nicolucci A, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Khunti K; DISCOVER Investigators. Charbonnel BH, et al. Among authors: fenici p. Diabetes Obes Metab. 2023 Jan;25(1):46-55. doi: 10.1111/dom.14842. Epub 2022 Sep 16. Diabetes Obes Metab. 2023. PMID: 36111434 Free PMC article.
All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK.
Ling S, Zaccardi F, Vlacho B, Li P, Real Gatius J, Mata-Cases M, Franch-Nadal J, Kosiborod MN, Gillies C, Fenici P, Mauricio D, Shah BR, Khunti K. Ling S, et al. Among authors: fenici p. Diabetes Obes Metab. 2023 Jan;25(1):132-143. doi: 10.1111/dom.14856. Epub 2022 Sep 26. Diabetes Obes Metab. 2023. PMID: 36056765 Free PMC article.
82 results